Why GLP-1 trials rarely measured what you eat, and why it matters

If you are on a GLP-1 medication and have wondered why nobody handed you a clear diet plan to go with it, there is a reason. The clinical trials that got these drugs approved barely measured what people ate. A new review of 129 trials just put a number on that gap, and it explains a lot about why nutrition advice for GLP-1 users still feels like guesswork.

TL;DR

A 2025 scoping review in Advances in Nutrition examined 129 randomized trials of injectable weight-loss drugs, including semaglutide and tirzepatide. Only 36 collected any dietary data and just 10 reported it. No trial tracked fiber, supplement use, or overall diet quality, and no tirzepatide trial reported food intake at all. The practical message: the nutrition guidance you get rests on indirect evidence, so watching your own protein and micronutrient intake matters more, not less.

What the review actually looked at

The review came from a team at the University of California, Davis (Demsina Babazadeh, Shawna Wyatt and Francene Steinberg) and was published in the journal Advances in Nutrition in August 2025. It is a scoping review, which means the authors did not run a new trial. They gathered every randomized controlled trial they could find on injectable anti-obesity medications and asked one plain question: across all this research, how much did anyone actually measure or report about what participants were eating?

The pool was large. 129 trials in total: 54 on liraglutide, 43 on semaglutide, 22 on tirzepatide, and 10 head-to-head comparisons. Many ran for a year or longer, from 30 to 104 weeks, and enrolled thousands of people between them. If diet during GLP-1 therapy were being studied properly anywhere, this is where it would show up.

How little diet actually got measured

It mostly did not. The headline numbers are hard to defend once you see them laid out:

• Of 129 trials, only 36 (28%) collected any dietary data at all, and just 10 (8%) reported dietary outcomes.
• For semaglutide, 10 of those trials gathered diet data, but only 2 reported it.
• For tirzepatide, the newest and most powerful of the group, only 3 trials collected diet data and none reported food intake at all.
• Just 3 studies in the entire pool reported any change in macronutrients (roughly 15 g less carbohydrate, 5 g less protein and 9 g less fat per day).
• Not a single trial reported fiber intake, micronutrient intake, or whether participants took supplements.
• Not one used a recognised diet-quality score, such as the Healthy Eating Index, to judge whether people were eating well or simply eating less.

The large pivotal programs you have probably heard of, STEP and SUSTAIN for semaglutide, SURPASS and SURMOUNT for tirzepatide, enrolled huge numbers of people and tracked cardiometabolic endpoints in fine detail. Diet was not on the measurement list. As the authors put it, most of these trials "fail to report meaningful diet quality or food intake data."

There is a second blind spot. Fewer than half the trials (57 of 129) reported giving participants any lifestyle or diet counseling at all, and a registered dietitian was clearly the one delivering it in only 16 of them. So the trials did not just rarely measure what people ate, most did not consistently support it either. That is a striking omission for a class of drugs whose entire effect runs through eating less.

Why a missing measurement is your problem, not just theirs

Here is the uncomfortable part. These drugs work by cutting how much you eat. In the trials that did measure it, semaglutide reduced energy intake by 24 to 35% compared with placebo, and liraglutide by a similar margin. Eating far less food is the mechanism, not a side effect.

But eating less is not the same as eating well. If almost no trial recorded what people actually ate, then nobody has solid trial data on whether GLP-1 users hit a sensible protein target, whether their intake of vitamins and minerals dropped below what the body needs, or whether supplements closed the gap. The review says this plainly: current nutrition guidelines for GLP-1 users lean on "indirect evidence due to the scarcity of dietary intake data." In other words, the standard advice to get enough protein and watch your micronutrients is reasonable extrapolation, not something these trials proved.

That gap is not academic. It sits exactly where the difference between losing fat and losing muscle lives, and where staying nourished shades into slow deficiency. When the evidence base is this thin, the responsibility quietly shifts onto you and your clinician to manage what the trials never bothered to track.

What quietly runs short when you eat less

When total intake falls by a quarter or more, the nutrients most likely to come up short are the ones already tight in a typical Western diet. A few stand out for GLP-1 users:

• Protein. This is the one that protects your muscle. Research suggests 30 to 40% of the weight lost on a GLP-1 can be lean mass rather than fat, and low protein intake makes that worse. We go deeper in our piece on muscle loss and protein intake on GLP-1.
• Fiber. Eat less food and fiber usually falls with it, which feeds the constipation so many users complain about. None of the trials tracked it.
• Vitamin B12, vitamin D, iron and magnesium. These are the micronutrients most often flagged when intake drops, and they drive real symptoms - fatigue, hair thinning, low mood, muscle cramps. Early findings suggest deficiency rates climb the longer someone stays on treatment.

This is the exact gap GLP-1 Shield is built to close: the specific nutrients that drain away when a medication cuts your intake, rather than a random handful of pills. Research on the precise nutritional needs of GLP-1 users is still early, so the honest approach is to monitor and target, not to megadose.

What to do while the science catches up

You do not have to wait for better trials to protect yourself. Treat this as a plan to build with your prescriber or a dietitian, not a set of rules to self-apply.

1. Put protein first at every meal. Because your appetite is low, you often only get through a few bites, so make them count. Many clinicians suggest aiming for 1.2 to 1.6 g of protein per kg of body weight, though that exact target has not been tested head-to-head in these trials.
2. Get baseline and follow-up bloodwork. Ask for vitamin B12, vitamin D, iron or ferritin, and magnesium checked before you start and again a few months in. Our monitoring guide lays out a sensible schedule.
3. Cover the basics deliberately. A targeted supplement aimed at the nutrients most likely to fall short beats guessing with whatever is in the cupboard.
4. Keep fiber up as your plate shrinks. Vegetables, legumes and whole grains first, or a fiber supplement if you cannot manage the volume of food.
5. Track what you actually eat for a week or two. The trials never did, so become your own dataset. A short food log shows you fast whether your protein and produce are where they should be.
6. Bring in a professional. Only 44% of these trials even reported lifestyle counseling, and only some of that came from a dietitian. A single session with one can catch gaps you would not spot on your own.

Frequently asked questions

Do GLP-1 medications cause nutrient deficiencies?

They can, indirectly. GLP-1 drugs cut how much you eat by 24 to 35% in trials, and when total intake drops, nutrients like vitamin B12, vitamin D, iron and magnesium can fall below what your body needs. The risk appears to grow the longer you stay on treatment, which is why periodic bloodwork is worth asking for.

Should I take supplements while on Ozempic or Wegovy?

For many people it is reasonable, but it is best guided by bloodwork rather than guesswork. Because appetite suppression makes it hard to eat a full, varied diet, a targeted supplement covering the nutrients most likely to run short - protein, B12, vitamin D, iron and magnesium - can help. Talk it through with your prescriber, especially if you take other medications.

How much protein should I eat on a GLP-1?

A commonly cited target is 1.2 to 1.6 g of protein per kg of body weight per day, aimed at protecting muscle while you lose fat. That figure comes from broader weight-loss research, not from GLP-1 trials specifically, since almost none measured protein intake. Prioritising protein at the start of each meal is the practical way to hit it on a small appetite.

Why didn't my doctor give me a diet plan with my GLP-1?

Partly because the trials behind these drugs rarely studied diet, so there is little standardised, drug-specific guidance to hand out. A 2025 review found only 8% of GLP-1 and related trials reported dietary outcomes, and none tracked fiber or supplements. That leaves diet advice down to individual clinicians, many of whom are stretched for time. Asking for a dietitian referral is a fair request.